Anagenesis Biotechnologies

Developer of small molecules and cell therapy to treat genetic diseases

placeIllkirch Graffenstaden, Grand Est, France calendar_todayFounded 2011 groups9 employees language anagenesis-biotech.com

Innovation

4 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 100 times.

YearFilings
20201
20222
20231

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Private equity150%
Coming soon